NDC 54575-278
SILK
Bombyx Mori Fiber
SILK is a Percutaneous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Allergy Laboratories, Inc.. The primary component is Bombyx Mori Fiber.
| Product ID | 54575-278_dbe7bebd-e445-4e59-8302-e706b795fbde |
| NDC | 54575-278 |
| Product Type | Human Prescription Drug |
| Proprietary Name | SILK |
| Generic Name | Bombyx Mori Fiber |
| Dosage Form | Injection, Solution |
| Route of Administration | PERCUTANEOUS; SUBCUTANEOUS |
| Marketing Start Date | 1967-12-07 |
| Marketing Category | BLA / BLA |
| Application Number | BLA101376 |
| Labeler Name | Allergy Laboratories, Inc. |
| Substance Name | BOMBYX MORI FIBER |
| Active Ingredient Strength | 1 g/20mL |
| Pharm Classes | Non-Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Insect Proteins [CS],Silk [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
Packaging
NDC 54575-278-50
50 mL in 1 VIAL, MULTI-DOSE (54575-278-50)
| Marketing Start Date | 1967-12-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 54575-278-50 [54575027850]
SILK INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA101376 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1967-12-07 |
| Inactivation Date | 2020-01-31 |
NDC 54575-278-30 [54575027830]
SILK INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA101376 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1967-12-07 |
| Inactivation Date | 2020-01-31 |
NDC 54575-278-10 [54575027810]
SILK INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA101376 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1967-12-07 |
| Inactivation Date | 2020-01-31 |
NDC 54575-278-02 [54575027802]
SILK INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA101376 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1967-12-07 |
| Inactivation Date | 2020-01-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| BOMBYX MORI FIBER | 1 g/20mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Insect Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Insect Proteins [CS]
- Silk [CS]
- Allergens [CS]
NDC Crossover Matching brand name "SILK" or generic name "Bombyx Mori Fiber"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-1117 | Silk | Silk |
| 36987-1118 | Silk | Silk |
| 36987-1119 | Silk | Silk |
| 36987-1120 | Silk | Silk |
| 54575-278 | SILK | bombyx mori fiber |
Trademark Results [SILK]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 SILK 98831353 not registered Live/Pending |
Cameron, Timothy A 2024-10-31 |
SILK 98831353 not registered Live/Pending |
Glenn, Gary W 2024-10-31 |
SILK 98831353 not registered Live/Pending |
Gates, Jimmy E 2024-10-31 |
SILK 98831353 not registered Live/Pending |
Jenkins, Gary E 2024-10-31 |
SILK 98831353 not registered Live/Pending |
Rasboro, Johnathan L 2024-10-31 |
 SILK 98771563 not registered Live/Pending |
Blockchain Game Partners, Inc. 2024-09-26 |
 SILK 98771555 not registered Live/Pending |
Blockchain Game Partners, Inc. 2024-09-26 |
 SILK 98737476 not registered Live/Pending |
LONZA WALKERSVILLE, INC. 2024-09-06 |
 SILK 98204801 not registered Live/Pending |
Silknode 2023-09-29 |
 SILK 98155163 not registered Live/Pending |
KOKUYO KABUSHIKI KAISHA 2023-08-29 |
 SILK 98041170 not registered Live/Pending |
Holonym Foundation 2023-06-13 |
 SILK 97797683 not registered Live/Pending |
Johnson & Johnson 2023-02-16 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.